Drug intelligence / Profile preview

Lactobebe S

Development stage: Unknown
Lead developer: Toa Pharmaceuticals
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactobebe S is a pediatric probiotic product marketed by Sam-A Pharmaceutical in South Korea, in-licensed from the Japanese company TOA Pharmaceutical. It is specifically formulated for infants and children to support gut health and treat digestive disturbances such as diarrhea, constipation, and indigestion. The product contains a synergistic combination of live biotherapeutic strains, typically including *Bacillus mesentericus*, *Clostridium butyricum*, and *Enterococcus faecalis*. These strains work in concert to modulate the intestinal microbiota, promoting the growth of beneficial bacteria (such as Bifidobacteria) while inhibiting the proliferation of harmful pathogens. This microbial balance helps to stabilize the intestinal barrier and improve overall digestive function.

Brand names: Lactobebe SLactobebe
Other names: probiotic product

Beyond the preview

Go deeper on Lactobebe S.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobebe S.

Explore the full profile